Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression

Modern Pathology

Volumn 24, Issue 6, 2011, Pages 810-819

  Yu, Tsan Hua ^a,b   Yuan, Ray Hwang ^b   Chen, Yu Ling ^a,b   Yang, Wan Ching ^a,b   Hsu, Hey Chi ^a,b   Jeng, Yung Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

cholangiocarcinoma; cholangiole; N cadherin; viral hepatitis

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN; MUCIN 2; NERVE CELL ADHESION MOLECULE;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TISSUE DIFFERENTIATION; VIRUS HEPATITIS;

ALPHA-FETOPROTEINS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CADHERINS; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CHOLANGIOCARCINOMA; FEMALE; GENES, RAS; HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; MUTATION; TUMOR MARKERS, BIOLOGICAL;

EID: 79957884920     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.41     Document Type: Article

References (31)

1. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarci-noma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 2002;17:1049-1055. (Pubitemid 35013958)
2. Kurathong S, Lerdverasirikul P, Wongpaitoon V, et al. Opisthorchis viverrini infection and cholangiocarcino-ma: a prospective, case-controlled study. Gastroenter-ology 1985;89:151-156. (Pubitemid 15057924)
3. Lim MK, Ju YH, Franceschi S, et al. Clonorchis sinensis infection and increasing risk of cholangiocar-cinoma in the Republic of Korea. Am J Trop Med Hyg 2006;75:93-96. (Pubitemid 351627576)
4. Ohta G, Nakanuma Y, Terada T. Pathology of hepato-lithiasis: cholangitis and cholangiocarcinoma. Prog Clin Biol Res 1984;152:91-113.
5. Tamir BM. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol 2007;19:615-617.
6. Lazaridis KN, Gores GJ. Primary sclerosing cholangitis and cholangiocarcinoma. Semin Liver Dis 2006;26:42-51. (Pubitemid 43320726)
7. Lipshutz GS, Brennan TV, Warren RS. Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg 2002;195:713-718. (Pubitemid 35285406)
8. Kobayashi M, Ikeda K, Saitoh S, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000;88:2471-2477. (Pubitemid 30331952)
9. Lee TY, Lee SS, Jung SW, et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 2008;103:1716-1720.
10. Andersona CD, Pinsona CW, Berlinb J, et al. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004;9:43-57.
11. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003;10:288-291. (Pubitemid 37407518)
12. Jang KT, Hong SM, Lee KT, et al. Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection. Virchows Arch 2008;453:589-598.
13. Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 2001;34:651-658. (Pubitemid 32927987)
14. Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005;189:120-125. (Pubitemid 40215518)
15. Zhang F, Chen XP, Zhang W, et al. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histo-pathology 2008;52:224-232.
16. Hai S, Kubo S, Yamamoto S, et al. Clinicopathologic characteristics of hepatitis C virus-associated intrahe-patic cholangiocarcinoma. Dig Surg 2005;22:432-439.
17. Lee CH, Chang CJ, Lin YJ, et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 2009;100:1765-1770.
18. Zhou H, Wang H, Zhou D, et al. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepa-tocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer 2010;46: 1056-1061.
19. Chen DS. Viral hepatitis in East Asia. J Formos Med Assoc 1996;95:6-12.
20. Chen CH, Yang PM, Huang GT, et al. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007;106:148-155.
21. Mosnier J-F, Kandel C, Cazals-Hatem D, et al. N-cadherin serves as diagnostic biomarker in intrahe-patic and perihilar cholangiocarcinomas. Mod Pathol 2009;22:182-190.
22. Tannapfel A, Sommerer F, Benicke M, et al. Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut 2003;52:706-712. (Pubitemid 36528874)
23. Tada M, Omata M, Ohto M. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 1990;50:1121-1124. (Pubitemid 20083997)
24. Zhang Y, Bai XF, Huang CX. Hepatic stem cells: existence and origin. World J Gastroenterol 2003;9: 201-204. (Pubitemid 36215788)
25. Komuta M, Spee B, Borght SV, et al. Clinicopatholo-gical study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008;47:1544-1556. (Pubitemid 351702738)
26. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006;25:3818-3822. (Pubitemid 43980477)
27. Uenishi T, Kubo S, Yamamoto T, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Jpn J Cancer Res 2003;94: 851-857. (Pubitemid 37406966)
28. Torbenson M, Wang J, Abraham S, et al. Bile ducts and ductules are positive for CD56 (N-CAM) in most cases of extrahepatic biliary atresia. Am J Surg Pathol 2003;27:1454-1457. (Pubitemid 37315198)
29. Gütgemann I, Haas S, Berg JP, et al. CD56 expression aids in the differential diagnosis of cholangiocarcino-mas and benign cholangiocellular lesions. Virchows Arch 2006;448:407-411.
30. Steiner PE, Higginson J. Cholangiolocellular carcinoma of the liver. Cancer 1959;12:753-759.
31. Kim JH, Yoon HK, Ko GY, et al. Nonresectable combined hepatocellular carcinoma and cholangiocar-cinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 2010;255:270-277.